Articles by Dr. Ron Laethem

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.